Publications
2021
A MULTI-CENTRE AUDIT OF LOWER GASTROINTESTINAL BLEEDING MANAGEMENT
Davies, M., Townsend, T., Razanskaite, V., Morgan, J., Baig, D., Fox, J., . . . Smith, P. (2021). A MULTI-CENTRE AUDIT OF LOWER GASTROINTESTINAL BLEEDING MANAGEMENT. In GUT Vol. 70 (pp. A224). doi:10.1136/gutjnl-2020-bsgcampus.428
COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY
Townsend, T., Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., . . . Subramanian, S. (2021). COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY. In GUT Vol. 70 (pp. A127). doi:10.1136/gutjnl-2020-bsgcampus.237
2020
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease
Townsend, T., Razanskaite, V., Dodd, S., Storey, D., Michail, S., Morgan, J., . . . Subramanian, S. (2020). Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease. Alimentary Pharmacology and Therapeutics, 52(8), 1341-1352. doi:10.1111/apt.16057
2019
MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE
Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., Watters, C., . . . Subramanian, S. (2019). MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE. In GUT Vol. 68 (pp. A100). doi:10.1136/gutjnl-2019-BSGAbstracts.190
Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
Townsend, T., Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., . . . Subramanian, S. (2019). Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S407-S408). doi:10.1093/ecco-jcc/jjy222.710
2018
IMMUNE CHECKPOINT INHIBITOR COLITIS- A REVIEW OF CURRENT MANAGEMENT TRENDS
Swaminathan, M., Olsson-Brown, A., Subramaniam, S., & Pritchard, M. (2018). IMMUNE CHECKPOINT INHIBITOR COLITIS- A REVIEW OF CURRENT MANAGEMENT TRENDS. In GUT Vol. 67 (pp. A203). doi:10.1136/gutjnl-2018-BSGAbstracts.405
Outcomes of single or sequential dual modality loco-regional therapies in Hepatocellular carcinoma
Balachandrakumar, V. K., Swaminathan, M., Evans, J., Kibriya, N., Palmer, D., & Cross, T. (2018). Outcomes of single or sequential dual modality loco-regional therapies in Hepatocellular carcinoma. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S206). doi:10.1016/S0168-8278(18)30625-1
Hepatic encephalopathy: current challenges and future prospects
Swaminathan, M., Ellul, M. A., & Cross, T. J. S. (2018). Hepatic encephalopathy: current challenges and future prospects. HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 10, 1-11. doi:10.2147/HMER.S118964
2017
A 5-YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS
Skouras, T., Bonnet, L., Swaminathan, M., Mcgalliard, R., Metussin, A., Evans, J., . . . Ramesh, J. (2017). A 5-YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS. In GUT Vol. 66 (pp. A40). doi:10.1136/gutjnl-2017-314472.74
A 6 YEAR SINGLE CENTRE EXPERIENCE OF AUTOMATED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA
Cross, T., Ding, W., Swaminathan, M., Farrell, C., Kibriya, N., & Evans, J. (2017). A 6 YEAR SINGLE CENTRE EXPERIENCE OF AUTOMATED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA. In GUT Vol. 66 (pp. A162). doi:10.1136/gutjnl-2017-314472.317
OUTCOMES OF SINGLE OR SEQUENTIAL DUAL MODALITY LOCO-REGIONAL THERAPIES IN HEPATOCELLULAR CARCINOMA
Cross, T., Swaminathan, M., Kibriya, N., & Evans, J. (2017). OUTCOMES OF SINGLE OR SEQUENTIAL DUAL MODALITY LOCO-REGIONAL THERAPIES IN HEPATOCELLULAR CARCINOMA. In GUT Vol. 66 (pp. A162-A163). doi:10.1136/gutjnl-2017-314472.318
USE OF THE ENHANCED LIVERPOOL LIVER ABDOMINAL RATIO (ELAAR) TO PREDICT OUTCOME IN PATIENTS ASSESSED FOR TRANSJUGULAR INTRAHEPATIC PORTO-SYSTEMIC SHUNT (TIPS)
Swaminathan, M., Smith, L., Kibriya, N., Kumar, P., & Cross, T. (2017). USE OF THE ENHANCED LIVERPOOL LIVER ABDOMINAL RATIO (ELAAR) TO PREDICT OUTCOME IN PATIENTS ASSESSED FOR TRANSJUGULAR INTRAHEPATIC PORTO-SYSTEMIC SHUNT (TIPS). In GUT Vol. 66 (pp. A91-A92). doi:10.1136/gutjnl-2017-314472.177
2016
HOW TO USE CROSS-SECTIONAL IMAGING TO ASSESS PROGNOSIS IN END-STAGE CIRRHOSIS WITH THE USE OF ELAAR (THE ENHANCED LIVERPOOL ABDOMINAL AREA RATIO) AND SOFTWARE ASSISTED LIVER VOLUME
Smith, L. C., Alam, S., Farrell, C., Swaminathan, M., Chidambaram, V., & Cross, T. (2016). HOW TO USE CROSS-SECTIONAL IMAGING TO ASSESS PROGNOSIS IN END-STAGE CIRRHOSIS WITH THE USE OF ELAAR (THE ENHANCED LIVERPOOL ABDOMINAL AREA RATIO) AND SOFTWARE ASSISTED LIVER VOLUME. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S270). doi:10.1016/S0168-8278(16)00313-5